Carmed Pharmaceuticals, a Turkey-based company specializing in standardized carvacrol-based formulations, announced that select products are now available on OneLavi.com, a curated online marketplace for beauty, health, and wellness brands. The launch represents a significant milestone in the company's ongoing expansion into the United States market, following its previously announced plans to broaden availability through multiple digital retail channels, including Amazon.
Through OneLavi.com, U.S. consumers can now access several of Carmed's flagship formulations, including Vacrol® Kids Spray, a carvacrol-based spray for children ages 4-11; S-Mix®, designed to support immune function; Vacrol® Capsule, a standardized carvacrol formulation; and Vacrol-M® Capsule, a multi-component botanical formulation. Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified. All formulations are developed using standardized processes to ensure consistency, reproducibility, and quality control.
Carmed states that OneLavi's curated marketplace aligns with its long-term strategy of introducing its formulations through platforms that emphasize quality, product transparency, and wellness-focused discovery. 'Launching on OneLavi represents an important step in making our formulations accessible to consumers in the United States,' said Mustafa Can, Founder of Carmed Pharmaceuticals. 'We believe curated wellness platforms provide an environment where consumers can better understand the value of standardized, research-driven formulations.'
The company's formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to broader scientific investigation involving carvacrol-based formulations and multicomponent botanical interactions. Carmed emphasizes that this research reflects scientific investigation into botanical bioactivity and formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.
Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, and expanded consumer accessibility. 'We are excited to officially introduce Carmed to OneLavi's wellness-focused audience,' said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. 'This launch supports our broader vision of building a trusted international wellness brand as we continue expanding throughout the United States.'
